Literature DB >> 11134020

Overexpression of N-acetylglucosaminyltransferase III enhances the epidermal growth factor-induced phosphorylation of ERK in HeLaS3 cells by up-regulation of the internalization rate of the receptors.

Y Sato1, M Takahashi, Y Shibukawa, S K Jain, R Hamaoka, Y Yaginuma, K Honke, M Ishikawa, N Taniguchi.   

Abstract

N-Acetylglucosaminyltransferase III (GnT-III) is a key enzyme that inhibits the extension of N-glycans by introducing a bisecting N-acetylglucosamine residue. In this study we investigated the effect of GnT-III on epidermal growth factor (EGF) signaling in HeLaS3 cells. Although the binding of EGF to the epidermal growth factor receptor (EGFR) was decreased in GnT-III transfectants to a level of about 60% of control cells, the EGF-induced activation of extracellular signal-regulated kinase (ERK) in GnT-III transfectants was enhanced to approximately 1.4-fold that of the control cells. A binding analysis revealed that only low affinity binding of EGF was decreased in the GnT-III transfectants, whereas high affinity binding, which is considered to be responsible for the downstream signaling, was not altered. EGF-induced autophosphorylation and dimerization of the EGFR in the GnT-III transfectants were the same levels as found in the controls. The internalization rate of EGFR was, however, enhanced in the GnT-III transfectants as judged by the uptake of (125)I-EGF and Oregon Green-labeled EGF. When the EGFR internalization was delayed by dansylcadaverine, the up-regulation of ERK phosphorylation in GnT-III transfectants was completely suppressed to the same level as control cells. These results suggest that GnT-III overexpression in HeLaS3 cells resulted in an enhancement of EGF-induced ERK phosphorylation at least in part by the up-regulation of the endocytosis of EGFR.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11134020     DOI: 10.1074/jbc.M008551200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

Review 1.  Glycosylation alterations in lung and brain cancer.

Authors:  Hassan Lemjabbar-Alaoui; Andrew McKinney; Yi-Wei Yang; Vy M Tran; Joanna J Phillips
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

Review 2.  The bisecting GlcNAc in cell growth control and tumor progression.

Authors:  Hazuki E Miwa; Yinghui Song; Richard Alvarez; Richard D Cummings; Pamela Stanley
Journal:  Glycoconj J       Date:  2012-04-04       Impact factor: 2.916

3.  Surfactant protein D suppresses lung cancer progression by downregulation of epidermal growth factor signaling.

Authors:  Y Hasegawa; M Takahashi; S Ariki; D Asakawa; M Tajiri; Y Wada; Y Yamaguchi; C Nishitani; R Takamiya; A Saito; Y Uehara; J Hashimoto; Y Kurimura; H Takahashi; Y Kuroki
Journal:  Oncogene       Date:  2014-03-10       Impact factor: 9.867

4.  The bisecting GlcNAc on N-glycans inhibits growth factor signaling and retards mammary tumor progression.

Authors:  Yinghui Song; Jason A Aglipay; Joshua D Bernstein; Sumanta Goswami; Pamela Stanley
Journal:  Cancer Res       Date:  2010-04-15       Impact factor: 12.701

5.  Conformational stability of the epidermal growth factor (EGF) receptor as influenced by glycosylation, dimerization and EGF hormone binding.

Authors:  Eric S Taylor; Laercio Pol-Fachin; Roberto D Lins; Steven K Lower
Journal:  Proteins       Date:  2017-01-18

6.  A complex between phosphatidylinositol 4-kinase IIα and integrin α3β1 is required for N-glycan sialylation in cancer cells.

Authors:  Tomoya Isaji; Sanghun Im; Akihiko Kameyama; Yuqin Wang; Tomohiko Fukuda; Jianguo Gu
Journal:  J Biol Chem       Date:  2019-01-18       Impact factor: 5.157

7.  Suppression of heregulin β signaling by the single N-glycan deletion mutant of soluble ErbB3 protein.

Authors:  Motoko Takahashi; Yoshihiro Hasegawa; Yoshitaka Ikeda; Yoshinao Wada; Michiko Tajiri; Shigeru Ariki; Rina Takamiya; Chiaki Nishitani; Motoko Araki; Yoshiki Yamaguchi; Naoyuki Taniguchi; Yoshio Kuroki
Journal:  J Biol Chem       Date:  2013-10-04       Impact factor: 5.157

8.  High levels of E4-PHA-reactive oligosaccharides: potential as marker for cells with characteristics of hepatic progenitor cells.

Authors:  Nozomi Sasaki; Kenta Moriwaki; Naofumi Uozumi; Katsuhisa Noda; Naoyuki Taniguchi; Akihiko Kameyama; Hisashi Narimatsu; Shunsaku Takeishi; Masao Yamada; Nobuto Koyama; Eiji Miyoshi
Journal:  Glycoconj J       Date:  2009-12       Impact factor: 2.916

Review 9.  Glycosylation in cancer: mechanisms and clinical implications.

Authors:  Salomé S Pinho; Celso A Reis
Journal:  Nat Rev Cancer       Date:  2015-08-20       Impact factor: 60.716

Review 10.  Role of N-glycans in growth factor signaling.

Authors:  Motoko Takahashi; Takeo Tsuda; Yoshitaka Ikeda; Koichi Honke; Naoyuki Taniguchi
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.